Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients

Figure 1

Cytotoxic activity of SAHA and paclitaxel on ovarian cancer cells. A, ovarian cancer cell lines; B, patient-derived ovarian cancer cells. Cells were incubated with SAHA or paclitaxel for 72 hours, and cytotoxic effects were assessed by Alamar Blue assay. Cell viabilities are expressed as the ratio of absorbance of treated to untreated cells. Means ± SD of 2 (ASC-OC-1), 3 (ASC-OC-2 to ASC-OC-5), or 4 (cell lines) independent experiments in quadruplicates are shown.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us